Up to 13% of Dementia Cases May Be Reversible and Treatable

Recent findings suggest that up to 13% of dementia diagnoses may actually involve conditions that are both reversible and treatable, raising important questions about diagnostic accuracy and the potential for improved patient outcomes through early intervention.

A Diagnostic Dilemma: Dementia or Liver Disease?

The aging process often brings concerns about memory loss and cognitive decline. Yet, research from the United States has shaken this assumption: nearly 13% of people diagnosed with dementia may actually be suffering from a different, treatable condition—hepatic encephalopathy. This finding, published in 2024, challenges the perception that cognitive impairment in older adults is always irreversible.

The Overlooked Impact of Liver Health

When the liver falters in its essential roles—filtering blood, maintaining chemical balance—the effects ripple throughout the body. Beyond well-known complications like kidney or heart issues, it’s the brain that can suffer most insidiously. In fact, more than 40% of patients with advanced cirrhosis develop hepatic encephalopathy, a disorder whose symptoms—memory lapses, falls, tremors, even hallucinations—can easily masquerade as classic dementia.

Several factors explain this diagnostic confusion:

• The overlap between neuropsychiatric symptoms of liver failure and those of degenerative brain diseases
• Lack of routine liver screening among patients presenting with cognitive complaints
• Persistent healthcare disparities affecting minority populations’ access to specialist evaluation

Inequality and Missed Opportunities in Diagnosis

A closer look at data from over 177,000 former U.S. military personnel diagnosed with dementia revealed an unexpected pattern. Under the leadership of hepatologist Jasmohan Bajaj, researchers at the Virginia Commonwealth University found a significant proportion had elevated FIB-4 scores—a marker indicating advanced liver fibrosis—without ever being tested for liver disease. Expanding their study to nearly 69,000 civilians confirmed that close to 13% shared these alarming indicators. Strikingly, non-white patients were disproportionately affected, highlighting ongoing inequities in access to specialized care.

Hope Through Early Detection and Prevention

Amid these findings lies a message of hope: hepatic encephalopathy is often reversible with appropriate treatment. Lifestyle changes—healthy diet, regular physical activity—and early intervention remain powerful tools. Promising drug therapies are on the horizon, while experimental data in mice suggests even age-related liver changes could potentially be rolled back if caught soon enough.

As Dr. Bajaj succinctly puts it: “This connection between liver health and cognitive decline really underscores why targeted screening is so crucial—to ensure patients get treatments that can truly change lives.”